AZ divests rights to Arimidex and Casodex
Juvisé has paid upfront $181 million to AZ for the medicines
Read More
Tag: anastrozole
NICE backs use of drugs for breast cancer prevention
The National Institute for Health and Care Excellence has now published updated familial breast cancer guidelines which advocate the use of three medicines to reduce the risk of developing the disease.
Read More
NICE backs anastrozole for breast cancer prevention
The National Institute for Health and Care Excellence is now backing the use of three medicines to prevent breast cancer in women with a family history of the disease, adding anastrozole to the mix for the first time.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
